VBI Vaccines Inc logo

VBI Vaccines Inc

C$ 4.82 (-5.12%) Mar 23
P/E:
At Loss
P/B:
3.18
Market Cap:
C$ 308.86M ($ 239.31M)
Enterprise V:
C$ 245.82M ($ 190.46M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap C$:
308.86M
Market Cap $:
239.31M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value C$:
245.82M
Enterprise Value $:
190.46M
PB Ratio:
3.18
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

VBI Vaccines Inc
NAICS : 325412 SIC : 3741
160 Second Street, Floor 3, Cambridge, MA, USA, 02142
Description
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Name Current Vs Industry Vs History
Cash-To-Debt 2.47
Equity-to-Asset 0.61
Debt-to-Equity 0.32
Debt-to-EBITDA -0.35
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.08
Distress
Grey
Safe
Beneish M-Score -4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % 0.41
12-1 Month Momentum % -28.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.29
Quick Ratio 2.19
Cash Ratio 2.03
Days Inventory 98.96
Days Sales Outstanding 41.03
Days Payable 128.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38.4

Financials (Next Earnings Date:2022-11-08 Est.)

TSX:VBV's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.842
EPS (TTM) (C$) 0
Beta 0
Volatility % 69.7
14-Day RSI 0
14-Day ATR (C$) 0
20-Day SMA (C$) 0
12-1 Month Momentum % -28.68
52-Week Range (C$) 3.85 - 7.6
Shares Outstanding (Mil) 64.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VBI Vaccines Inc Filings

Document Form Filing Date
No Filing Data